The effect of small dose of topiroxostat on serum uric acid in patients receiving hemodialysis
Discussion: It is suggested that a low dose of topiroxostat decreased serum uric acid sufficiently to maintain it below 7.0 mg/dL in patients receiving hemodialysis.
Source: Hemodialysis International - Category: Hematology Authors: Yume Nagaoka, Yoshiko Tanaka, Hiroshi Yoshimoto, Rie Suzuki, Kakei Ryu, Mio Ueda, Minako Akiyama, Miho Nagai, Yoshitaka Miyaoka, Eiichiro Kanda, Shinnichi Iwai, Michio Nagaoka, Yoshihiko Kanno Tags: Original Article Source Type: research
More News: Allopurinol | Antidoxidants | Clinical Trials | Dialysis | Hematology | Hemodialysis | Japan Health | Study